← Browse by Condition
Medical Condition

intellectual disability

Total Trials
5
Recruiting Now
5
Trial Phases
EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for intellectual disability sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — intellectual disability Clinical Trials

How many clinical trials are currently recruiting for intellectual disability?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for intellectual disability, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intellectual disability?
intellectual disability research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intellectual disability clinical trial?
Eligibility criteria for intellectual disability trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Children's Mercy Hospital Kansas City 1 trial
National Taiwan University Hospital 1 trial
Hôpital le Vinatier 1 trial
Yongguo Yu 1 trial
RWTH Aachen University 1 trial

Recruiting Clinical Trials

NCT07624448
Recruiting

Regulating Together for Intellectual Disability: A Group Behavioral Therapy for for Emotion Dysregulation in Autism and Intellectual Disability

Enrollment
10 pts
Location
United States
Sponsor
Children's Mercy Hospital Kans...
View Trial →
NCT06737627
Recruiting

Development and Validation of the Observatory Battery of Common Eye Disorders for Adults With Intellectual Disability

Enrollment
1,400 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT04025398
Recruiting

A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability

Enrollment
116 pts
Location
France
Sponsor
Hôpital le Vinatier
View Trial →
NCT06860672 EARLY_Phase 1
Recruiting

Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation

Enrollment
1 pts
Location
China
Sponsor
Yongguo Yu
View Trial →
NCT04781452
Recruiting

Evaluating the Treatment in the MZEB Aachen

Enrollment
2,000 pts
Location
Germany
Sponsor
RWTH Aachen University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology